Review of Current Evidence and Comparison of Guidelines for ...
Review of Current Evidence and Comparison of Guidelines for ...
Review of Current Evidence and Comparison of Guidelines for ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EUR/03/5045931<br />
page 52<br />
Authors, year<br />
Mashkillejson A.L.,<br />
et al., 1997 (8)<br />
Petrenko L..А., 1996<br />
(9)<br />
Skripkin J.K., et al.,<br />
1998 (10)<br />
Loseva O.K., et al.,<br />
1998 (11)<br />
Akovbian V.A., et al.,<br />
1998 (12)<br />
Fedorova L.D., et al.,<br />
1998 [13]<br />
Chebotarev V.V., et<br />
al., 1999 [14]<br />
No. <strong>of</strong><br />
patients<br />
Table 3. Results <strong>of</strong> the treatment <strong>of</strong> syphilis diseased patients with Benzatinpenicillin<br />
Distribution under diagnoses<br />
Results <strong>of</strong> the treatment<br />
Seroconversion Seroresistance<br />
Primary Secondary Latent Primary Secondary Latent Primary Secondary Latent<br />
Serological<br />
relapse<br />
Clinical<br />
relapse<br />
366 127 156 83 100% 96% – –<br />
346 129 143 74 100% 100% 100% – –<br />
142 142 91.5% 8.5% – –<br />
406 50 206 150 100% 92% 93.4% – 4.8% 4.1% 2.5% 0.28%<br />
23 183 200 140 100% 99% 91.5% – 1% 8.5% 0.3% –<br />
140 59 67 100% 100% – – – –<br />
237 Is not present the data under<br />
diagnoses<br />
97.5% 2.5% 0.84% 2.5%
Change language